MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 401–500 of 828
Macro advances in microRNAs and myocardial regeneration
Wang, J., & Martin, J. F. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000050 · Cited by 29
Rivera‐Barahona, A., Fulgencio-Covián, A., Pérez‐Cerdá, C., Ramos, R., Barry, M. A., Ugarte, M., Pérez, B., Richard, E., & Desviat, L. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-06420-8 · Cited by 33
MicroRNAs in right ventricular remodelling
Bátkai, S., Bär, C., & Thum, T. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx153 · Cited by 33
“expression is of great interest as this microRNA has been found to be key in cardiac apoptosis and aging.(27) The transition to maladaptive RV hypertrophy is associated with a decrease in RV- Hypoxia-inducible factor-1a (Hif1a) which is a target of miR-199a.”
BackgroundRole of miRNA in the Regulatory Mechanisms of Estrogens in Cardiovascular Ageing
Pérez‐Cremades, D., Mompeón, A., Vidal‐Gómez, X., Hermenegildo, C., & Novella, S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6082387 · Cited by 33
“miR-34 is part of a well-described family of ageingassociated miRNAs related to cardiomyocyte apoptosis [190] and vascular cell senescence [191, 192].”
BackgroundCassani, M., Fernandes, S., Vrbský, J., Ergir, E., Cavalieri, F., & Forte, G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00323 · Cited by 32
Roles of non-coding RNA in diabetic cardiomyopathy
Yao, X., Huang, X., Chen, J., Lin, W., & Tian, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02252-9 · Cited by 29
Liu, Y., Wang, L., Li, X., Han, W., YANG, K. Y., Wang, H., Zhang, Y., Su, R., Liu, Z., Wang, R., et al. (2017) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2017.12.009 · Cited by 37
MicroRNA‐638 inhibits human aortic valve interstitial cell calcification by targeting Sp7
Jiao, W., Zhang, D., Wang, D., Xu, R., Tang, L., Zhao, M., & Xu, R. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14405 · Cited by 29
Nastase-Rusu, E.-G., Lupan, A., Marinescu, C. I., Neculachi, C. A., Preda, M. B., & Burlacu, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.810241 · Cited by 30
“Notably, numerous basic and clinical studies have connected miRNA to the initiation and/or progression of hypertrophy and fibrosis (11, 12), which make them exciting potential therapeutic targets in these conditions.”
BackgroundRuan, L., Mendhe, B., Parker, E. J., Kent, A., Isales, C. M., Hill, W., McGee‐Lawrence, M. E., Fulzele, S., & Hamrick, M. W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.742004 · Cited by 41
“Mir-34a is elevated with aging in tissues ranging from cardiac muscle (Boon et al., 2013) to skeletal muscle (Zheng et al.”
BackgroundSun, J., Pi, F., Ji, J., Lei, H., Gao, Z., Zhang, Y., Habimana, J. D. D., Li, Z., & Sun, X. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04051 · Cited by 28
Devulder, J. V., Baker, J. R., Fenwick, P. S., Odqvist, L., Donnelly, L., & Barnes, P. J. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0183oc · Cited by 30
Tang, B., Xuan, L., Tang, M., Wang, H., Zhou, J., Liu, J., Wu, S., Li, M., Wang, X., & Zhang, H. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.08.024 · Cited by 27
Vavassori, C., Cipriani, E., & Colombo, G. I. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.47 · Cited by 36
MicroRNA-34a: A Novel Therapeutic Target in Fibrosis
Zhao, M., Qi, Q., Liu, S., Huang, R. S., Shen, J., Zhu, Y., Chai, J., Zheng, H., Wu, H., & Liu, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.895242 · Cited by 30
MicroRNAs in Cardiovascular Disease: Perspectives and Reality
Παπαγεωργίου, Ν., Tsalamandris, S., Giolis, A., & Tousoulis, D. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000078 · Cited by 29
“Moreover, researchers demonstrated that inhibition of the miR-15 family from an early postnatal age increases myocyte proliferation in the adult heart and improves left ventricular systolic function after adult MI.131 Further experimental studies with RNA isolated from hearts of mice subjected to increased cardiac aft…”
BackgroundInfluentialMiR34 inhibition induces human heart progenitor proliferation
Iannolo, G., Sciuto, M. R., Raffa, G. M., Pilato, M., & Conaldi, P. G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0400-9 · Cited by 30
“Boon et al.(7) have shown that miR34 is involved in cardiac aging and its downmodulation through LNA inhibition supports cardiac repair in mice after AMI (acute myocardial infarction).”
BackgroundTong, N., Jin, R., Zhou, Z., & Wu, X. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00137 · Cited by 26
“Notably, miR-34a is significantly upregulated in aged hearts and can promote the senescence of cardiac myocytes and decrease systolic function by inhibiting the expression of protein phosphatase 1 nuclear-targeting subunit and inducing telomere shortening (Boon et al., 2013).”
BackgroundA comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection
Mahdavi, S. Z. B., Jebelli, A., Aghbash, P. S., Baradaran, B., Amini, M., Oroojalian, F., Pouladi, N., Baghi, H. B., de la Guárdia, M., & Mokhtarzadeh, A. (2024) · Medicinal Research Reviews · doi:10.1002/med.22073 · Cited by 27
Cardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets
Zheng, P., Yan, W., Ding, Y.-N., Zhang, Y., Chen, Z., Qian, J., & Ge, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02630-7 · Cited by 39
“66 Long noncoding RNAs (lncRNAs), although less evolutionarily conserved than miRNAs, play emerging roles in cardiac ageing through senescence pathway modulation.”
Exosomes and MicroRNAs in Biomedical Science
Mirzaei, H., Rahimian, N., Mirzaei, H. R., Nahand, J. S., & Hamblin, M. R. (2022) · Synthesis lectures on biomedical engineering · doi:10.2200/s01171ed1v01y202202bme062 · Cited by 32
Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs
Cagnin, S., Brugnaro, M., Millino, C., Pacchioni, B., Troiano, C., Sante, M. D., & Kaludercic, N. (2022) · Cells · doi:10.3390/cells11172697 · Cited by 31
Bernardo, B. C., Yildiz, G. S., Kiriazis, H., Harmawan, C. A., Tai, C. M. K., Ritchie, R. H., & McMullen, J. R. (2022) · Cells · doi:10.3390/cells11193117 · Cited by 26
“To explore potential reasons as to why inhibiting miR-34a provided limited protection in the diabetic heart, we first examined the expression of miR-34 target genes, some of which were previously shown to be regulated in settings of cardiac protection (vinculin (Vcl), Bcl2, Bcl6, cyclin D1, Notch1, Pnuts, Pofut1, Sema…”
BackgroundResultNon-Coding RNAs in Cardiac Aging
Wang, H., Bei, Y., Shi, J., Xiao, J., & Kong, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430141 · Cited by 27
microRNA expression profiling of heart tissue during fetal development.
Zhou, J., Dong, X.-R., Zhou, Q.-J., Wang, H.-J., Qian, Y.-Y., Tian, W.-D., Ma, D., & Li, X.-T. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1691 · Cited by 23
Epigenetic targets in cancer and aging: dietary and therapeutic interventions
Khan, S. U., Shukla, S., Sinha, S., & Meeran, S. M. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1132702 · Cited by 27
“upregulated in aging tissues.[102] Recently, miRNA34a has been shown to promote cellular senescence in vascular smooth muscle cells by SIRT1 downregulation.”
BackgroundPhosphatase 1 Nuclear Targeting Subunit (PNUTS) Regulates Aurora Kinases and Mitotic Progression
Wang, F., Wang, L., Fisher, L. A., Li, C., Wang, W., & Peng, A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0670 · Cited by 28
Functional role of miR-34a in diabetes and frailty
Mone, P., Donato, A. D., Varzideh, F., Kansakar, U., Jankauskas, S. S., Pansini, A., & Santulli, G. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.949924 · Cited by 26
“Specifically, miR-34a has been associated to frailty, aging, and diabetes (Figure 1) (Boon et al., 2013; Chakraborty et al., 2014; Rippo et al., 2014; Badi et al., 2018; Thounaojam and Bartoli, 2019; Kukreti and Amuthavalli, 2020; Ni et al., 2020; Manakanatas et al., 2022) and is generally considered a bona fide bioma…”
BackgroundWinbanks, C. E., Ooi, J. Y., Nguyen, S. S., McMullen, J. R., & Bernardo, B. C. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12281 · Cited by 20
Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
Ebner, O. A., & Selbach, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092166 · Cited by 25
“Finally, the miR-34 family has recently been reported to be also involved in neuronal and cardiovascular diseases [69,70].”
BackgroundBasso, D., Padoan, A., Laufer, T., Aneloni, V., Moz, S., Schrörs, H., Pelloso, M., Saiz, A., Krapp, M., Fogar, P., et al. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.11.005 · Cited by 25
Self-citationA miRNA catalogue and ncRNA annotation of the short-living fish Nothobranchius furzeri
Baumgart, M., Barth, E., Savino, A., Groth, M., Koch, P., Petzold, A., Arisi, I., Platzer, M., Marz, M., & Cellerino, A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3951-8 · Cited by 34
“Mir-29 family members are up-regulated during aging in a variety of different tissues including muscle, skin, brain and aorta [2, 18, 46, 54, 56, 66] and appear to be key regulators of age-dependent gene expression [6, 51].”
BackgroundIsserlin, R., Merico, D., Wang, D., Vuckovic, D., Bousette, N., Gramolini, A. O., Bader, G. D., & Emili, A. (2014) · Molecular BioSystems · doi:10.1039/c4mb00265b · Cited by 32
Toba, A., Kariya, T., Aoyama, R., Ishiyama, T., Tsuboko, Y., Takeda, K., Fujimoto, H., Shimokado, K., & Harada, K. (2017) · Blood Pressure · doi:10.1080/08037051.2017.1306422 · Cited by 24
Wang, G., Yu, M., & Wang, G. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111319 · Cited by 24
MicroRNA-mediated control of myocardial infarction in diabetes
Pérez‐Cremades, D., Chen, J., Assa, C. R., & Feinberg, M. W. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.01.004 · Cited by 26
MicroRNAs regulating signaling pathways in cardiac fibrosis: potential role of the exercise training
Caria, A. C. I., Rodrigues, L. F., Joaquim, V. H. A., Sousa, R. A. L. D., Fernandes, T. M., & de Oliveira, E. M. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00410.2023 · Cited by 25
Improved risk stratification in prevention by use of a panel of selected circulating microRNAs
Keller, T., Boeckel, J., Groß, S., Klotsche, J., Palapies, L., Leistner, D. M., Pieper, L., Stalla, G. K., Lehnert, H., Silber, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04040-w · Cited by 25
Self-citationXia, W., & Hou, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8438 · Cited by 29
“Additionally, the expression of miR-34a increases with age and is involved in the regulation of telomere maintenance and DNA damage responses, providing a potential mechanism through which telomeres erode during ageing (12).”
InfluentialMicroRNA‑34a mediates atrial fibrillation through regulation of Ankyrin‑B expression
Zhu, Y. K., Feng, Z., Cheng, W. N., & Xiao, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8873 · Cited by 27
“Recently, miR‑34a was noted for its significant effect on the development of fibrosis (18) and, in particular, of cardiac fibrosis (12,13).”
Li, Q., Wang, C., Cai, L., Lu, J., Zhu, Z., Wang, C., Su, Z., & Lu, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9800 · Cited by 25
A Roadmap for Fixing the Heart: RNA Regulatory Networks in Cardiac Disease
Tang, R., Long, T., Lui, K. O., Chen, Y., & Huang, Z.-P. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.007 · Cited by 25
Xiang, W., Lin, H., Wang, Q., Chen, W., Liu, Z., Chen, H., Zhang, H., & Chen, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5901 · Cited by 24
MicroRNAs and therapeutic potentials in acute and chronic cardiac disease
Song, R., & Zhang, L. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104179 · Cited by 23
Regulating translation in aging: from global to gene-specific mechanisms
Solyga, M., Majumdar, A., & Besse, F. (2024) · EMBO Reports · doi:10.1038/s44319-024-00315-2 · Cited by 29
Role of noncoding RNAs in cardiac ageing
Varghese, L. N., Schwenke, D. O., & Katare, R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1142575 · Cited by 23
Apoptosis And Myocardial Infarction: Role Of Ncrnas And Exosomal Ncrnas
Farokhian, A., Rajabi, A., Sheida, A., Abdoli, A., Rafiei, M., Jazi, Z. H., Asouri, S. A., Morshedi, M. A., Hamblin, M. R., Adib-Hajbagheri, P., et al. (2023) · Epigenomics · doi:10.2217/epi-2022-0451 · Cited by 23
Payne, C. T., Tabassum, S., Wu, S., Hu, H., Gusdon, A. M., Choi, H. A., & Ren, X. S. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1278334 · Cited by 25
Dimitrakopoulou, K., Vrahatis, A. G., & Bezerianos, A. (2015) · BMC Genomics · doi:10.1186/s12864-015-1256-3 · Cited by 24
“[8] which named it as cardiac aging biomarker (the dataset of the study is used in our analysis).”
BackgroundInfluentialFisher, L. A., Wang, L., Wu, L., & Peng, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572149 · Cited by 23
Sex-specific associations between telomere length and candidate miRNA expression in placenta
Tsamou, M., Martens, D. S., Cox, B., Madhloum, N., Vrijens, K., & Nawrot, T. S. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1627-z · Cited by 23
“Upregulated miR-34a was identified in aged human hearts, involving a novel direct miR34a target, Phosphatase 1 Nuclear Targeting Subunit (PNUTS) which reduced telomere shortening [78].”
BackgroundRegulatory Mechanisms of Mitochondrial Function and Cardiac Aging
Lin, R., & Kerkelä, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041359 · Cited by 27
“Given the well-accepted documentation of cardiomyocyte death/loss in the aged myocardium [1,61,71] and the lack of evidence of cardiac aging at cellular and molecular level, it can be debated whether killing senescent cells, especially senescent cardiomyocytes, is an effective strategy in restoring aging-related decli…”
BackgroundInfluentialRoles of microRNAs in pressure overload- and ischemia-related myocardial remodeling
Zhou, S., Liu, Y., Prater, K., Zheng, Y., & Cai, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.08.023 · Cited by 22
Post-Transcriptional Regulation of Molecular Determinants during Cardiogenesis
Lozano-Velasco, E., García‐Padilla, C., Muñoz-Gallardo, M. D. M., Martínez-Amaro, F. J., Caño-Carrillo, S., Castillo-Casas, J. M., Sánchez–Fernández, C., Aránega, A. E., & Franco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052839 · Cited by 24
“For example, miR-19a is essential for correct heart development [154], and, of particular importance is miR-34a, which has been previously described playing a protecting role against cardiac remodeling in a stress situation [155].”
BackgroundBadiola, I., Santaolalla, F., García-Gallastegui, P., del Rey, A. S., Unda, F. J., & Ibarretxe, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.03.004 · Cited by 24
“We mentioned before that this miRNA induces cardiomycyte senescence (Boon et al., 2013).”
BackgroundInfluentialAging: Treating the Older Patient
Rosko, A. E., & Artz, A. S. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.11.007 · Cited by 22
Alcohol‐mediated miR‐34a modulates hepatocyte growth and apoptosis
Iwagami, Y., Zou, J., Zhang, H., Cao, K. Y., Ji, C., Kim, M., & Huang, C. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13681 · Cited by 23
“Although the role of miR-34a in cancer malignant progression might be controversial, there is one study investigating miR-34a in cardiac fibrosis and demonstrating that knockout of miR-34a might reduce fibrosis progression through the protein, serine/threonineprotein phosphatase 1 regulatory subunit 10.(37) As fibrosi…”
BackgroundWang, F., Zhu, S., Fisher, L. A., Wang, L., Eurek, N. J., Wahl, J. K., Lan, L., & Peng, A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1673 · Cited by 24
“A potential role of PNUTS in DDR was supported by another study showing that PNUTS upregulation attenuated DNA damage-induced cell death in cardiomyocytes (19).”
BackgroundResultInfluentialFlorijn, B. W., Valstar, G., Duijs, J. M. G. J., Menken, R., Cramer, M. J., Teske, A. J., Ghossein‐Doha, C., Rutten, F. H., Spaanderman, M. E. A., den Ruijter, H. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70848-8 · Cited by 22
Zhu, L. W., Zhang, X., Yuan, R., & Chai, Y. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132901 · Cited by 22
Sarlak, Z., Eidi, A., Ghorbanzadeh, V., Moghaddasi, M., & Mortazavi, P. (2023) · BioFactors · doi:10.1002/biof.1979 · Cited by 22
“9,10 MiR-34a has been related to the regulation of sirtuin 1 (SIRT1) protein 11 that was observed in endothelial cells (ECs) and endothelial progenitor cells (EPCs).”
Cellular Senescence: A Bridge Between Diabetes and Microangiopathy
Liu, J., Guo, B., Liu, Q., Zhu, G., Wang, Y., Wang, N., Yang, Y., & Fu, S. (2024) · Biomolecules · doi:10.3390/biom14111361 · Cited by 23
“Many reports have highlighted the important role of vascular endothelial cell senescence in producing ROS and pro-inflammatory responses.”
Small Molecules with Big Impacts on Cardiovascular Diseases
Azad, F. M., Arabian, M., Maleki, M., & Malakootian, M. (2020) · Biochemical Genetics · doi:10.1007/s10528-020-09948-z · Cited by 22
Lu, Z. Z., Wu, S., Xiao, Z., Song, J., Wu, H., & Peng, X. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114412 · Cited by 24
Guo, Y., Zhou, F., Fan, J., Wu, T., Jia, S., Li, J., & Chen, N. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310136 · Cited by 24
MicroRNA expression in the aging mouse thymus
Ye, Y., Li, D., Ouyang, D., Deng, L., Zhang, Y., Ma, Y., & Li, Y. (2014) · Gene · doi:10.1016/j.gene.2014.06.039 · Cited by 21
MicroRNAs in Right Ventricular (dys)function (2013 Grover Conference Series)
Thum, T., & Bátkai, S. (2014) · Pulmonary Circulation · doi:10.1086/675981 · Cited by 21
“Especially the increase in miR-34a expression is of interest, as this miRNA has recently been described as playing a key role in cardiac apoptosis and aging.(11) Other miRNAs that typically increased during cardiac fibrosis of the left ventricle, such as miR-21,(7) were also increased in right heart hypertrophy–associ…”
BackgroundEpigenetic regulation in cardiac fibrosis
Yu, L., & Xu, Y. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i11.784 · Cited by 22
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
Mayr, C., Beyreis, M., Wagner, A., Pichler, M., Neureiter, D., & Kiesslich, T. (2016) · BioMed Research International · doi:10.1155/2016/4805270 · Cited by 21
“PNUTS is a protein that regulates telomere length and its overexpression reduces telomere shortening as well as apoptotic events connected with telomere shortening [41].”
BackgroundSelected serum microRNA, abdominal aortic calcification and risk of osteoporotic fracture
Pickering, M., Millet, M., Rousseau, J., Croset, M., Szulc, P., Borel, O., Sornay‐Rendu, E., & Chapurlat, R. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216947 · Cited by 21
Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model
Lu, J., Chen, A., Ma, X., Shang, X., Zhang, Y., Guo, Y., Liu, M., & Wang, X. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000114 · Cited by 21
“Last but not least, aging is a major risk factor for myocardial disease, which promotes changes in the structure and function of the heart, leading to deterioration in some patients with acute myocardial infarction (Boon et al., 2013; Roh et al., 2016).”
BackgroundChen, D., Zhang, Z., Lu, X., & Yang, X. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1819336 · Cited by 21
“2011) and miR-34a (Boon et al .”
RetractedmiR‐34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin‐1
Zhang, X., Zhang, G., & Bai, Z. (2020) · Cell Biology International · doi:10.1002/cbin.11512 · Cited by 20
Xia, W., Chang, B., Li, L., Hu, T., Ye, J., Chen, H., Li, W., Zan, T., & Hou, M. (2021) · Aging · doi:10.18632/aging.203743 · Cited by 23
“Although several studies have examined the regulation of cardiac senescence by microRNAs [11, 12], less is known about their functional roles in this context.”
BackgroundPcsk6 Deficiency Promotes Cardiomyocyte Senescence by Modulating Ddit3-Mediated ER Stress
Zhan, W., Chen, L., Liu, H., Long, C., Liu, J., Ding, S., Wu, Q., & Chen, S. (2022) · Genes · doi:10.3390/genes13040711 · Cited by 22
“It was reported that age-related cardiac apoptosis may be regulated by microRNA-34a targeting the serine/threonine-protein phosphatase 1 regulatory subunit 10 (PNUTS) gene [5].”
BackgroundmiR-34a expands myeloid-derived suppressor cells via apoptosis inhibition
Huang, A., Zhang, H., Chen, S., Xia, F., Yang, Y., Dong, F., Sun, D., Xiong, S., & Zhang, J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.04.010 · Cited by 20
“Moreover, miR-34a directly targets Protein phosphatase 1 nuclear targeting subunit (PNUTS) to reduce cardiomyocytes apoptosis [37].”
BackgroundRole of circulating factors in cardiac aging
Cannata, A. N., Marcon, G., Cimmino, G., Camparini, L., Ciucci, G., Sinagra, G., & Loffredo, F. S. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.95 · Cited by 21
“Indeed, elevated levels of miR-34 are found in the heart of old mice (170) and the inhibition of its downstream target, the protein phosphatase-1 regulatory subunit-10 (PNUTS) is associated with increased cardiomyocyte apoptosis, telomere attrition and cardiac contractile impairment, typical hallmarks of cardiac aging…”
BackgroundRNA therapeutics for heart disease
Majo, F. D., & Windt, L. J. D. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.037 · Cited by 21
Accelerated Cardiac Aging in Patients With Congenital Heart Disease
Iacobazzi, D., Alvino, V. V., Caputo, M., & Madeddu, P. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.892861 · Cited by 19
“young mouse hearts, miRNA-22 overexpression was shown to be involved in aging-related cardiac fibrosis, while the aging-induced expression of miR-34 was associated to contractile dysfunction during age (103, 104).”
BackgroundFan, A., Wang, Q., Yuan, Y., Cheng, J.-L., Chen, L., Guo, X., Li, Q., Chen, B., Huang, X., & Huang, Q. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00102.2015 · Cited by 19
Huston, J., & Ryan, J. J. (2016) · Pulmonary Circulation · doi:10.1086/687765 · Cited by 20
“Interestingly, miRNA-34a plays a role in apoptosis and cellular aging as proapoptotic.(72) In addition, miRNA-145/143, miRNA-204, and miRNA-17 appear to play an important role in RV function, and many more likely play a role in RV homeostasis.”
BackgroundSousa, L. O., Sobral, L. M., Matsumoto, C. S., Saggioro, F. P., López, R. V. M., Panepucci, R. A., Curti, C., Silva, W. A., Greene, L. J., & Leopoldino, A. M. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.11.001 · Cited by 19
MicroRNAs and Heat Shock Proteins in Breast Cancer Biology
Yıldız, M. T., Tutar, L., GİRİTLİOĞLU, N. I., Bayram, B., & Tutar, Y. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1170-8_15 · Cited by 19
miRNAs As Potential Molecular Targets in Heart Failure
Katz, M. G., Fargnoli, A. S., Williams, R. D., Kendle, A. P., Steuerwald, N., & Bridges, C. R. (2014) · Future Cardiology · doi:10.2217/fca.14.64 · Cited by 20
MicroRNA-34a induces apoptosis in PC12 cells by reducing B-cell lymphoma 2 and sirtuin-1 expression
Lin, Q., Mao, Y., Song, Y., & Huang, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4185 · Cited by 20
“Current research has revealed that ectopic overexpression of microRNA-34a (miR-34a) can induce cell cycle arrest, apoptosis and senescence to inhibit cancer recurrence, migration and metastasis (9,10).”
Endothelial microRNAs and long noncoding RNAs in cardiovascular ageing
Bink, D. I., Pauli, J., Mäegdefessel, L., & Boon, R. A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.03.019 · Cited by 19
Self-citationShikonin inhibits adipogenic differentiation via regulation of mir-34a-FKBP1B
Jang, Y. J., Jung, C. H., Ahn, J., Gwon, S. Y., & Ha, T. Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.039 · Cited by 18
“In addition, age-induced expression of mir-34a regulates cardiac aging and function [37].”
Shikonin attenuates sympathetic remodeling in chronic heart failure mice via regulating miR-124
Wen-lin, L., & Liu, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.038 · Cited by 18
Zhang, F., Wang, K., Gao, F., Xuan, Y., Liu, X., & Zhang, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632375 · Cited by 18
“MiR-34a expression levels were significantly increased in the animal model of acute MI and in the aged hearts (Boon et al., 2013) and were strongly connected with heart remolding at 1 year after acute MI (Matsumoto et al., 2013).”
BackgroundMicroRNA-34a Promotes Ischemia-Induced Cardiomyocytes Apoptosis through Targeting Notch1
Pan, J., Zhou, L., Lin, C., Xue, W., Chen, P., & Lin, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1388415 · Cited by 19
“Moreover, miR-34a has been noted to be upregulated over time in cardiomyocytes with cardiac injury and in patients with heart failure [10, 11].”
BackgroundMicroRNAs Inducing Proliferation of Quiescent Adult Cardiomyocytes
Pandey, R., & Ahmed, R. P. H. (2015) · Cardiovascular Regenerative Medicine · doi:10.14800/crm.519 · Cited by 20
Voronina, N., Lemcke, H., Wiekhorst, F., Kühn, J., Rimmbach, C., Steinhoff, G., & David, R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.06.015 · Cited by 18
Serum Extracellular Vesicles Retard H9C2 Cell Senescence by Suppressing miR-34a Expression
Liu, Y., Liu, Z., Xie, Y., Zhao, C., & Xu, J. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9847-4 · Cited by 18
Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease
Calway, T., & Kim, G. H. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414552902 · Cited by 17
“Finally, miR-34a was found by multiple groups to reduce fibrosis and increase angiogenesis in MI or pressure overload models.(66,67) Nevertheless, therapeutic targets need to be selected carefully or directed toward specific tissue beds because decreased fibrosis everywhere may lead to susceptibility to other ailments…”
MethodTelomere dynamics during aging in polygenic left ventricular hypertrophy
Marques, F. Z., Booth, S. A., Prestes, P. R., Curl, C. L., Delbridge, L. M. D., Lewandowski, P. A., Harrap, S. B., & Charchar, F. J. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00083.2015 · Cited by 19
“It 207 also plays a role in the regulation of anti-apoptotic effects in cardiomyocytes (3).”
BackgroundInfluentialThe roles of non-coding RNAs in cardiac regenerative medicine
Choong, O. K., Lee, D. S., Chen, C.-Y., & Hsieh, P. C. H. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.06.001 · Cited by 19
Integrative Analysis of miRNA and mRNA Expression Profiles Associated With Human Atrial Aging
Yao, Y., Jiang, C., Wang, F., Yan, H., Long, D., Zhao, J., Wang, J., Zhang, C., Li, Y., Tian, X., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01226 · Cited by 18
“By re-analyzing the miRNA microarray data generated by Boon et al. (2013), we also found that miR-23a differentially expressed between older mouse heart and younger mouse heart. miR-23a was firstly identified as a pro-hypertrophic miRNA (Lin et al., 2009).”
BackgroundKowara, M., Borodzicz-Jażdżyk, S., Rybak, K., Kubik, M., & Cudnoch‐Jędrzejewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115718 · Cited by 21
Ramos-Marquès, E., García‐Mendívil, L., Pérez‐Zabalza, M., Badules, H. S., Srinivasan, S., Oliveros, J. C., Torres‐Pérez, R., Cebollada, A., Vallejo‐Gil, J. M., Fresneda‐Roldán, P. C., et al. (2021) · Aging Cell · doi:10.1111/acel.13383 · Cited by 20
FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signaling
Subbaiah, K. C. V., Wu, J., Tang, W. H. W., & Yao, P. (2022) · JCI Insight · doi:10.1172/jci.insight.152783 · Cited by 17
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.